Federal Register of Legislation - Australian Government

Primary content

PB 11 of 2012 Determinations/Health as made
This Determination amends the National Health Act 1953 - Determination under section 84AH - Exempt items (PB 58 of 2007) to makes changes to the pharmaceutical items that are determined to be exempt items.
Administered by: Health
Registered 21 Feb 2012
Tabling HistoryDate
Tabled HR27-Feb-2012
Tabled Senate27-Feb-2012
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

PB 11 of 2012

Amendment Determination under section 84AH of the National Health Act 1953 (2012) (No.1)

 

National Health Act 1953

___________________________________________________________________________

 

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of

The Minister for Health, make this instrument under section 84AH of the National Health Act 1953.

Dated                 17                February 2012

 

 

 

 

 

 

 

 

 

 

 

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

___________________________________________________________________

 

 

 

 

 

1              Name of Instrument

 

(1)                This Instrument is the Amendment Determination under section 84AH of the National Health Act 1953 (2012) (No.1).

 

(2)                This Instrument may also be cited as PB 11 of 2012.

 

2              Commencement

                            This Instrument commences on 1 March 2012.

3              Amendments to PB 58 of 2007

                      Schedule 1 amends the legislative instrument titled Determination under section 84AH of the National Health Act 1953 (PB 58 of 2007) (as amended).

.

 


Schedule 1                   Amendments

 

      

 

[1]   Schedule 1, after entry for Metronidazole Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL :

            insert:

 

Mycophenolic Acid

Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL

Oral

 

[2]        Schedule 1, after entry for Ondansetron Syrup, 4 mg (as hydrochloride dehydrate) per 5 mL, 50 mL :

            insert:

 

Pantoprazole

Sachet containing granules 40 mg (as sodium sesquihydrate)

Oral

    

 

 

 

 

 

 

 

 

 

 

 

 

 

     

 

Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 

See http://www.frli.gov.au.